Mark W. Bêcher

6.1k citations

47 papers · 5.1k · 1 hit paper · h-index 24

Impact in

Neurology top 0.5%
- Amyotrophic Lateral Sclerosis Research
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
Cellular and Molecular Neuroscience top 0.5%
- Genetic Neurodegenerative Diseases

Papers in

Cellular and Molecular Neuroscience 20
- Genetic Neurodegenerative Diseases 19
- Hereditary Neurological Disorders 3
Neurology 16
- Neurological disorders and treatments 10
- Amyotrophic Lateral Sclerosis Research 4

Co-authors: Donald L. Price (9 shared papers)Sangram S. Sisodia (4 shared papers)Don W. Cleveland (4 shared papers)Lucie I. Bruijn (2 shared papers)Michael K. Lee (4 shared papers)David Borchelt (3 shared papers)Neal G. Copeland (2 shared papers)Jeffrey D. Rothstein (1 shared paper)
Journals: Proceedings of the National Academy of Sciences (4 papers)Journal of Neuropathology & Experimental Neurology (3 papers)Neurobiology of Disease (3 papers)Annals of Neurology (3 papers)Brain Pathology (3 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

Mark W. Bêcher

44 papers receiving 4.9k citations

Mark W. Bêcher's Hit Papers

align trajectories log scale

ALS-Linked SOD1 Mutant G85R Mediates Damage to Astrocytes and Promotes Rapidly Progressive Disease with SOD1-Containing Inclusions 1997 · 1.2k citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

1997 Neuron

Peers

Countries citing papers authored by Mark W. Bêcher

Since Specialization

Citations

This map shows the geographic impact of Mark W. Bêcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. Bêcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. Bêcher more than expected).

Fields of papers citing papers by Mark W. Bêcher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark W. Bêcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. Bêcher. The network helps show where Mark W. Bêcher may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark W. Bêcher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark W. Bêcher Line = papers co-authored together Mark W. Bêcher links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	ALS-Linked SOD1 Mutant G85R Mediates Damage to Astrocytes and Promotes Rapidly Progressive Disease with SOD1-Containing Inclusions Neuron ·Lucie I. Bruijn, Mark W. Bêcher, Michael K. Lee, Kenton L. Anderson, N.A. Jenkins, Neal G. Copeland, Sangram S. Sisodia, Jeffrey D. Rothstein Hit paper breakdown →	1997	1169
2	Presenilin 1 is required for Notch 1 and Dll1 expression in the paraxial mesoderm Nature ·Philip C. Wong, Hui Zheng, Hua Chen, Mark W. Bêcher, D.J.S. Sirinathsinghji, Myrna E. Trumbauer, Howard Y. Chen, Donald L. Price	1997	620
3	Genetic ablation of the t-SNARE SNAP-25 distinguishes mechanisms of neuroexocytosis Nature Neuroscience ·Philip Washbourne, Mario Carta, Edmar Tavares da Costa, James R. Mathews, Guillermina López‐Bendito, Zoltán Molnár, Mark W. Bêcher, Carlos Fernando Valenzuela	2001	440
4	Intranuclear Neuronal Inclusions in Huntington's Disease and Dentatorubral and Pallidoluysian Atrophy: Correlation between the Density of Inclusions andIT15CAG Triplet Repeat Length Neurobiology of Disease ·Mark W. Bêcher, Joyce A. Kotzuk, Alan H. Sharp, Stephen W. Davies, Gillian P. Bates, Donald L. Price, Christopher A. Ross	1998	368
5	Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine Nature Medicine ·Marcela Viviana Karpuj, Mark W. Bêcher, Joe E. Springer, Dorothée Chabas, Sawsan Youssef, Rosetta Pedotti, Dennis J. Mitchell, Lawrence Steinman	2002	334
6	Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis (ALS)-like disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant Proceedings of the National Academy of Sciences ·Lucie I. Bruijn, M. F. Beal, Mark W. Bêcher, Jörg Bernhard Schulz, Pauline Wong, Donald L. Price, Don W. Cleveland	1997	252
7	Overexpression of human copper,zinc-superoxide dismutase (SOD1) prevents postischemic injury Proceedings of the National Academy of Sciences ·Penghai Wang, Hua Chen, Honghua Qin, Sornampillai Sankarapandi, Mark W. Bêcher, Philip C. Wong, Jay Louis Zweier	1998	222
8	Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its enzymatic activity increases in Huntington’s disease brain nuclei Proceedings of the National Academy of Sciences ·Marcela Viviana Karpuj, Hideki Garren, Hilda H. Slunt, Donald L. Price, James F. Gusella, Mark W. Bêcher, Lawrence Steinman	1999	192
9	Neurofilament subunit NF-H modulates axonal diameter by selectively slowing neurofilament transport. The Journal of Cell Biology ·Joseph R. Marszalek, Toni L. Williamson, Michael K. Lee, Zuoshang Xu, Paul N. Hoffman, Mark W. Bêcher, Thomas O. Crawford, Don W. Cleveland	1996	160
10	Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin. Proceedings of the National Academy of Sciences ·Jie Bao, Alan H. Sharp, Molly V. Wagster, Mark W. Bêcher, Gabriele Schilling, Christopher A. Ross, Valina L. Dawson, Ted M. Dawson	1996	141
11	Evidence for Cholinergic Neurites in Senile Plaques Science ·Cheryl A. Kitt, Donald L. Price, Robert G. Struble, Linda C. Cork, Bruce H. Wainer, Mark W. Bêcher, William Cary Mobley	1984	129
12	Ligand-dependent activation of the hedgehog pathway in glioma progenitor cells Oncogene ·Moneeb Ehtesham, Ansul Sarangi, Juan Gerardo Valadez, Siprachanh Chanthaphaychith, Mark W. Bêcher, Ty William Abel, Reid C. Thompson, Michael K. Cooper	2007	118
13	The Neuropathology of CAG Repeat Diseases: Review and Update of Genetic and Molecular Features Brain Pathology ·Yves Robitaille, Íscia Lopes‐Cendes, Mark W. Bêcher, Guy Armand Rouleau, Arthur W. Clark	1997	110
14	Huntington Disease and the Related Disorder, Dentatorubral-Pallidoluysian Atrophy (DRPLA) Medicine ·Christopher A. Ross, Russell L. Margolis, Adam E Rosenblatt, Neal G. Ranen, Mark W. Bêcher, Elizabeth Aylward	1997	94
15	Axonal Transport of Mutant Superoxide Dismutase 1 and Focal Axonal Abnormalities in the Proximal Axons of Transgenic Mice Neurobiology of Disease ·David Borchelt, Philip C. Wong, Mark W. Bêcher, Carlos Pardo‐Villamizar, Michael K. Lee, Zuo-Shang Xu, Gopal Thinakaran, Nancy A. Jenkins	1998	88
16	Dentatorubral and pallidoluysian atrophy (DRPLA) Clinical and neuropathological findings in genetically confirmed north american and european pedigrees Movement Disorders ·Mark W. Bêcher, David Chaim Rubinsztein, Jayne Leggo, Molly V. Wagster, Oscar Colin Stine, Neal G. Ranen, Mary Louise Franz, Margaret H. Abbott	1997	86
17	Brain capillary telangiectasia: MR imaging appearance and clinicohistopathologic findings. Radiology ·R R Lee, Mark W. Bêcher, Mark L. Benson, Daniele Rigamonti	1997	84
18	Oculopharyngeal Muscular Dystrophy in Hispanic New Mexicans JAMA ·Mark W. Bêcher	2001	75
19	Huntington's Disease and Dentatorubral‐Pallidoluysian Atrophy: Proteins, Pathogenesis and Pathology Brain Pathology ·Christopher A. Ross, Mark W. Bêcher, Veronica Colomer, Simone Engelender, Jon D. Wood, Alan H. Sham	1997	58
20	Evidence for a role for transglutaminase in Huntington's disease and the potential therapeutic implications Neurochemistry International ·Marcela Viviana Karpuj, Mark W. Bêcher, Lawrence Steinman	2002	54

About Mark W. Bêcher

Mark W. Bêcher is a scholar working on Cellular and Molecular Neuroscience, Neurology, Genetics, Molecular Biology and Clinical Biochemistry, having authored 47 papers that have together received 5.1k indexed citations. Recurring topics across this work include Genetic Neurodegenerative Diseases (19 papers), Mitochondrial Function and Pathology (13 papers), Neurological disorders and treatments (10 papers), Muscle Physiology and Disorders (5 papers), Neurogenetic and Muscular Disorders Research (4 papers), Amyotrophic Lateral Sclerosis Research (4 papers), Hereditary Neurological Disorders (3 papers) and Glioma Diagnosis and Treatment (3 papers). The work is most often cited by research in Neurology (2.0k citations), Cellular and Molecular Neuroscience (2.0k citations), Genetics (763 citations), Neurology (547 citations) and Cell Biology (638 citations). Mark W. Bêcher has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Donald L. Price, Sangram S. Sisodia, Don W. Cleveland, Lucie I. Bruijn, Michael K. Lee, David Borchelt, Neal G. Copeland, Jeffrey D. Rothstein, Kenton L. Anderson and N.A. Jenkins. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Neuropathology & Experimental Neurology, Neurobiology of Disease, Annals of Neurology and Brain Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Mark W. Bêcher

Impact in

Papers in i

In The Last Decade

Mark W. Bêcher

Mark W. Bêcher's Hit Papers

Peers

Countries citing papers authored by Mark W. Bêcher

Fields of papers citing papers by Mark W. Bêcher

All Works

About Mark W. Bêcher

Explore authors with similar magnitude of impact

Papers in